PYC Therapeutics Ltd
ASX:PYC

Watchlist Manager
PYC Therapeutics Ltd Logo
PYC Therapeutics Ltd
ASX:PYC
Watchlist
Price: 1.51 AUD 0.67% Market Closed
Market Cap: 880.7m AUD

Wall Street
Price Targets

PYC Price Targets Summary
PYC Therapeutics Ltd

Wall Street analysts forecast PYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PYC is 3.72 AUD with a low forecast of 2.32 AUD and a high forecast of 5.33 AUD.

Lowest
Price Target
2.32 AUD
54% Upside
Average
Price Target
3.72 AUD
146% Upside
Highest
Price Target
5.33 AUD
253% Upside
PYC Therapeutics Ltd Competitors:
Price Targets
MDXG
MiMedx Group Inc
77% Upside
IVVD
Invivyd Inc
225% Upside
MGX
Metagenomi Inc
441% Upside
SYNACT
SynAct Pharma AB
30% Upside
MRSN
Mersana Therapeutics Inc
17% Upside
688105
Nanjing Vazyme Biotech Co Ltd
45% Upside
NGNE
Neurogene Inc
193% Upside
QURE
Uniqure NV
126% Upside

Revenue
Forecast

Revenue Estimate
PYC Therapeutics Ltd

For the last 13 years the compound annual growth rate for PYC Therapeutics Ltd's revenue is 22%. The projected CAGR for the next 3 years is 98%.

22%
Past Growth
98%
Estimated Growth
Estimates Accuracy
-47%
Average Miss

Operating Income
Forecast

Operating Income Estimate
PYC Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Net Income
Forecast

Net Income Estimate
PYC Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PYC's stock price target?
Price Target
3.72 AUD

According to Wall Street analysts, the average 1-year price target for PYC is 3.72 AUD with a low forecast of 2.32 AUD and a high forecast of 5.33 AUD.

What is PYC Therapeutics Ltd's Revenue forecast?
Projected CAGR
98%

For the last 13 years the compound annual growth rate for PYC Therapeutics Ltd's revenue is 22%. The projected CAGR for the next 3 years is 98%.

Back to Top